The Future of Veterinary Compounding Pharmacy: Advancements in Animal Medicine

The size of the animal drug compounding market surpassed $1 billion in 2021. It’s expected to grow even bigger according to projections by Transparency Market Research, which reckons a compound annual growth rate of over 7% between 2023 and 2031. As the size of this market keeps on expanding, with technological advancements also cropping up, we can expect to see new trends and techniques emerge. With the help of the best Compounding pharmacy Florida has to offer, we were able to map out a course into the future of animal medicine. Here are some of the advancements to expect as far as compounded medication for pets is concerned. 


Adoption of Nanotechnology

Nanotechnology in medicine has come a long way. It’s cropping up to be a viable way for veterinarians to overcome a critical issue when it comes to compounding medicine for animals and that’s drug resistance. This occurs when pathogens become immune to the conventional drugs that a pharmacy typically uses to treat a patient’s condition. 

To be more specific, pharmacies and veterinarians are beginning to experiment with nanotech for: 

  • Growth acceleration
  • More effective treatment regimens
  • Precise diagnostic processes

Besides tackling antibiotic resistance, some players are also leveraging the technology as delivery agents with the view to enhancing the efficacy of medications. While it’s still a fairly new concept on the scene, it’s one worth keeping your eye on.  


ML for bioactivity prediction

Wouldn’t it be helpful if a pharmacist could foresee how a pet will react to drug formulations before actually delivering it? With the aid of machine learning (ML), any veterinary compounding pharmacy can predict bioactivity. 

Bioactivity refers to how a living matter responds to a drug. This response could be adverse or beneficial. Intelligent algorithms, fuelled by real-world and historical data, could give pharmacists a peek into the future, more so when it comes to figuring outing bioactivity. The patterns unearthed can give a more accurate picture of interactions between ingredients themselves as well as compounds and cellular components in animals. Some of the AI-driven strategies for predicting bioactivity include molecular docking and QSAR modeling. 

Besides improving accuracy, machine learning can also improve turnaround time for compounding pharmacies.  


AI for optimal dosing 

Much in the same way that artificial intelligence can be put to work to illuminate possible side effects, so too can a pet medication pharmacy use it for combination analysis. 

Chronic conditions in pets like cancer require several drugs to treat, hence the need for compounding. Deep learning algorithms can ease the compounding process by drawing data from massive patient and drug datasets. Then it can use this information to pinpoint a suitable combination with the highest likelihood of delivering the most positive health outcome for the patient.

Beyond forecasting the synergistic effects of drug combinations, these algorithms can also use the aforementioned data sets to settle on optimal dosing metrics. The result is even more personalized compounding solutions according to unique patient factors, namely: 

  • Molecular characteristics
  • Genetic traits
  • Other biomarkers at large

Moreover, artificial intelligence can also identify problematic pathways that could lead to drug resistance. 


Onset of medicated feed additives

Human health has taken the proactive approach in recent years, more so with the spread of the coronavirus pandemic. Unfortunately, animal health has a long way to go before it can catch up. It is mostly reactive, with pet owners responding to pet symptoms rather than getting ahead of chronic conditions. 

But that could all be changing for pet parents and their loved ones as medicated feed additives catch on. These entail mineral and nutrient combinations that you can add to your pet’s meals to shore up deficits or bolster immunity. 

Valued at over $40 billion, the worldwide market for animal feed additives shows great promise.  The medicated feed additives niche, in particular, is also growing, with some pet compounding pharmacies combining different additives to improve feed efficiency and improve pet wellness. Statistics so far have shown that 7 in 10 of the brands in this field are combining various additives in a bid to amplify product efficacy. 


Popularity of chewable tablets

Pet owners have always had a tough time medicating their pets with traditional solutions such as OTC pills and drugs. Consequently, the answer has always been to turn to a compounding pharmacy Florida for alternative dosage or administration routes that are more acceptable to their loved ones. 

The development of flavored, chewable tablets has now made illegible a route of administration that has been traditionally problematic. Now, compound pharmacists can improve veterinary medicines by producing soft, chewable tablets available in a pet’s beloved taste such as:

  • beef
  • chicken
  • bacon 
  • tuna and more. 

Pet owners can now simply slip these tablets into the patient’s bowl of food, and they’ll be none the wiser. The popularity of compounded chewable tablets has risen in recent weeks, understandingly due to the convenience they provide, as well as the ability to take out allergens and expensive ingredients from contemporary pet medication. 


Taking to telemedicine

Telemedicine and telehealth are nothing new. But when it comes to the world of veterinary compounding, they might as well be novel technologies. Some pharmacies are using telehealth solutions to cut down on in-person visits between the pharmacy and the pet family. As a matter of fact, many pet medication compounding pharmacies today operate largely in the online space, leveraging various virtual tools to serve clients. 

Moreover, some telemedicine apps are enabling seamless collaboration between compounding pharmacists and veterinarians, easing the process of fulfilling prescription and compounding needs. This is further accelerated by the ability to share patient and drug data conveniently and accurately among all parties, while also providing home-based education for pet parents. 


Conclusion – Why adoption has been slow

Technologies like nanotech, artificial intelligence, and automation solutions show great promise. But there are a few hurdles that have obstructed more extensive implementation. One of the largest Achilles heels is the absence of data standardization, and in some cases, the lack of high-quality data needed to fuel artificial intelligence as well as non-receptive company cultures. Technical expertise and hefty financial investments have also been a stumbling block. Nonetheless, we’re confident veterinary compounding pharmacies will figure it out in time, and more players will begin to leverage some of these advancements in animal medicine into their workflows. For more insight on what’s simmering on the horizon, visit the Bay Life Pet Medication pharmacy website today.